TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
LQDA

Liquidia Technologies Inc

Healthcare · Drug Manufacturers - Specialty & Generic

71.00$ +5.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Liquidia Technologies Inc (LQDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 522 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LQDA
Line item Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
8.5 – – – 15 29 21 57 49 74 65 52 69 53 35 91 100 88 104 100 94 94 139 133 129 129 122 112 118 197 177 253 230 227 257 276 328 402 522
3.1 1.4 – – 5.5 19 9.5 48 40 61 53 41 56 41 24 81 66 55 71 67 61 62 109 103 100 100 93 83 90 168 147 214 185 177 196 227 191 333 438
1.4 -1.4 – – 3.4 18 9.2 48 40 61 52 39 56 40 24 80 65 54 68 64 57 58 104 98 93 94 88 76 84 158 133 204 176 170 173 157 191 223 284
– 1.4 – – 3.4 18 9.2 48 40 61 52 39 56 40 24 80 65 54 68 64 57 58 104 98 93 94 88 76 84 158 133 204 176 170 173 157 191 223 284
1.2 – – – 1.6 0.6 0.1 0.1 0.3 0.0 0.6 0.9 0.0 – – – – 0.6 3.0 3.1 3.0 3.3 3.8 3.1 5.0 4.1 4.1 3.3 4.1 2.6 3.2 4.2 2.7 1.2 10.0 36 54 74 109
– – – – 0.0 0.0 0.0 0.0 0.0 – 0.0 – – – – – – 0.0 0.0 0.0 – – 0.0 – – -4.1 0.0 – 0.0 3.5 7.2 0.0 0.2 1.3 6.4 25 24 29 36
4.3 – – – 8.2 8.4 8.5 8.2 8.1 11 11 11 12 11 11 7.4 9.5 8.9 8.4 7.9 7.4 7.0 6.5 6.1 6.3 – 6.1 – – – – – – – – – – – –
– – – – – – 0.0 0.0 – – – – – – – – 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9
– – – – – – 0.0 0.0 – – – – – – – – 5.5 5.2 4.9 4.5 4.4 4.2 4.0 3.8 3.7 3.6 3.6 3.5 3.4 3.4 3.3 3.2 3.2 3.1 3.1 3.0 3.0 2.9 2.8
27 – – – 49 33 34 29 31 36 33 33 34 31 27 26 28 26 25 27 28 38 37 38 39 47 61 64 71 111 115 142 153 178 242 254 283 293 327
12 – – – 31 14 15 7.6 8.2 11 12 14 17 16 13 14 12 7.9 7.0 7.1 7.3 8.0 6.8 7.5 8.8 6.8 19 12 19 22 24 34 42 61 78 103 136 150 189
2.9 8.7 – – 16 5.9 7.2 0.8 0.8 2.3 4.4 5.9 7.4 7.7 7.5 7.3 1.6 1.0 1.0 1.1 1.1 1.1 1.1 1.1 1.1 1.0 1.1 1.1 3.8 1.2 1.2 1.2 18 38 45 57 59 51 0.9
2.4 – – – 4.4 4.7 3.6 2.9 3.2 6.0 4.1 4.5 3.5 5.5 2.5 3.4 3.7 3.0 2.5 1.6 1.1 1.7 1.4 1.1 2.2 0.8 1.9 1.8 1.4 2.5 5.7 2.3 4.7 8.7 11 6.0 3.7 11 13
5.5 – – – 6.1 6.9 5.7 11 12 9.9 13 12 10 8.9 7.5 6.1 10 10 10 10 10 19 20 20 20 – – – 43 – – – 97 103 149 136 133 128 122
-18 -18 – – -34 -4.0 -13 28 19 37 32 20 35 22 8.9 65 71 63 79 73 65 55 102 95 90 82 61 48 47 86 63 111 77 50 15 22 45 109 195
-84 – – – -113 -141 -148 -157 -167 -181 -187 -201 -215 -230 -244 -259 -275 -284 -291 -298 -310 -326 -335 -344 -351 -362 -386 -402 -429 -470 -498 -521 -559 -596 -637 -641 -626 -573 -499
– 8.6 8.6 8.6 8.6 8.6 15 12 16 16 19 19 20 28 28 38 39 43 51 52 51 52 62 64 63 65 65 65 66 75 76 78 85 85 86 86 100 101 101

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?